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BACKGROUND: The purpose of this study was to examine the relationship between perceived social support and patient delay (PD)
among female and male cancer patients.
METHODS: A population-based study with register-sampled cancer patients was designed. Patient delay was defined as the time interval
between the patient’s experience of the first symptom and the first contact with a health-care professional. Both dates were provided
by the patients (n¼910). The patients completed a purpose-designed questionnaire, which assessed the patient’s perceptions of
how the partner reacted (‘Partner Avoidance’ and ‘Partner Support’) and how others in the social network responded (‘Other
Avoidance’ and ‘Other Support’) to the patient’s worries about the symptoms. The associations between the social support subscales
and PD were analysed separately for men and women.
RESULTS: In female patients, Partner Support and Other Support were associated with shorter PD, whereas Other Avoidance was
associated with longer PD. In the multivariate analysis, Other Avoidance remained associated with longer PD. Moreover, disclosure of
symptoms to someone reduced the likelihood of a long PD in female patients. In male patients, none of the social support scales
significantly increased or decreased the risk of a long PD in the univariate analysis, but Partner Support significantly decreased risk of a
long PD in the multivariate analysis.
CONCLUSIONS: The results of this study suggest that social support and avoidance from network members influence length of
PD differently in male and female cancer patients. This gender difference may explain previous mixed findings obtained in this field.
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Several studies have revealed associations between cancer mortal-
ity and indicators of social support such as perceived social
support, marital status and network size (Pinquart and Duberstein,
2009). The causal pathway is uncertain, but health behaviour may
be a mechanism that mediates the association between social
support and cancer mortality. For instance, members of the social
network may motivate cancer patients to implement a healthy diet
and encourage patients to avoid health-damaging behaviour such
as cigarette smoking and alcohol consumption (Pinquart and
Duberstein, 2009). The results of literature reviews suggest that
approximately 20–30% of cancer patients delay seeking help for
more than 3 months after having experienced possible symptoms
of cancer (Richards et al, 1999a; Tromp et al, 2005; Scott et al,
2008). As delay in cancer diagnosis and treatment is an important
factor for prognosis (Richards et al, 1999b), it is natural to ask
whether members of the social network may stimulate an
individual who experiences an unexplained symptom to seek
medical help, and whether people with a well-established network
are diagnosed earlier and hence have a better prognosis than
people with a constrained social network.
On the basis of the existing literature, it is not possible to draw a
definitive conclusion regarding the influence of social support on
patient delay (PD). One systematic review of delayed presentation
of breast cancer symptoms revealed no effect of marital status on
PD, but revealed that women who disclosed their discovery of a
symptom within a week of discovery were less likely to delay help
seeking (Ramirez et al, 1999). In a systematic review of PD in the
diagnosis of colorectal cancer, social networks and support were
identified as potentially important factors in reducing delay when
patients either sought advice from or made decisions based on the
experience of others (Mitchell et al, 2008). The level of evidence
was designated as moderate, that is, o75%, but more than or equal
to 50% of the studies considering the influence of social support on
PD provided evidence of such a relationship. A paper that
summarised the results of studies identified through the literature
searches to the above-mentioned two systematic reviews reported
that the influence of social support on PD appeared to vary by
cancer type (Macleod et al, 2009). For instance, lower levels of
social support were found to be associated with increased delay in
women with endometrial cancer, but unrelated to delay for lung,
upper gastrointestinal and urological cancers.
The mixed findings concerning the influence of social support
on PD may be explained by a number of factors. First, the existing
studies are heterogeneous with respect to operationalising social
support. Second, there is considerable variation in the cut-offs
used to designate long vs short PDs, and there is no gold standard
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sconcerning when is the right time to seek medical help for a
symptom. Whereas a long PD may be important for cancer
prognosis, a very short PD may be a consequence of somato-
sensory amplification, that is, the tendency to experience somatic
sensations as noxious and highly disturbing (Barsky, 1992), and
hypochondriacal beliefs and behaviour (Duddu et al, 2006).
A third factor responsible for the mixed findings may be that
none of the studies have addressed whether the influence of social
support provided by different sources varies by gender. This may
be relevant as previous studies have documented that men and
women benefit differently from the support provided by social
network members. For instance, the results of one study of a
randomly selected community sample of men and women showed
that women had larger networks of support and were more likely
to rely on friends and children for emotional support, whereas
men were more likely to rely exclusively on their partners
(Antonucci and Akiyama, 1987). In a study of gender, marital
status and the social control of health behaviour, it was seen that
marriage was associated with receipt of considerably more efforts
to control health for men than for women (Umberson, 1992). In
addition, married men were more likely to identify their spouse as
the one who tried to influence their health than married women.
Fourth, the vast majority of studies examining the association
between social support and PD have focused on the benefits of
social support. However, one’s social network is not always helpful
in times of crisis. Behaviour intended to be helpful may be
perceived as unsupportive by the patient and may thus have
negative consequences. Such behaviour could be uninvited advice,
generalising the unique experiences of the patient, enforced
cheerfulness and avoidance (Zakowski et al, 2003; Herzer et al,
2006). Thus, the benefits of talking with others depend on their
responses, and to our knowledge, no studies have addressed the
influence of negative social support on PD to date.
In the light of this, the objective of this study was to examine the
association between PD in cancer diagnosis and perceived social
support provided by the partner and other members of the social
network. Unlike previous studies, we explored whether the
association between social support and PD varied between female
and male patients, and whether perceived unsupportive behaviour
from the partner or other members of the network influenced PD.
MATERIALS AND METHODS
We performed a population-based study set in the Aarhus County,
Denmark, which has 640000 inhabitants and B3000 new cancer
cases diagnosed per year. More than 98% of the Danish citizens are
registered with a general practitioner (GP), who carries out initial
diagnostic investigations and refers patients to hospitals or
outpatient clinics when relevant.
The study population included all incident cancer patients
during the 1-year period from 1 September 2004 to 31 August 2005.
An incident cancer was defined as a new cancer diagnosis
excluding recurrent cancers of the same type. Thus, patients could
have had another cancer type earlier. Patients younger than
18 years and patients with non-melanoma skin cancers were
excluded. Patients were identified from the County Hospital
Discharge Registry (HDR), which for each hospital admission and
outpatient visit holds the patient’s unique civil registry number
(CRN), dates of admission and discharge and diagnoses classified
according to the International Classification of Diseases (ICD-10).
Data collection
We linked the patient’s CRN to the County HSR in order to
identify the patient’s GP. The patient’s GP was sent a questionnaire
asking the GP to confirm the diagnosis. Patients with a confirmed
diagnosis were sent a questionnaire, and non-responders received
a reminder after 3 weeks.
Patient delay
Patient delay was defined as the time interval between the date
when the patient experienced the first symptom and the date when
the patient made their first appointment with a health-care
professional. Both dates were provided by the patient. As length
of PD tend to be non-normally distributed, PD was classified as
‘short’, ‘medium’ or ‘long’ on the basis of 25th and 75th
percentiles: short PD, p25th percentile; medium PD, 425th to
p75th percentile; and long PD, 475th percentile.
Social support
For the purpose of this study, a social support questionnaire
consisting of 20 items was developed (see Appendix). The
questionnaire assessed the patient’s perceptions of how his/her
partner and how others in the social network reacted to the worries
associated with experiencing a symptom. ‘Others’ in the social
network were defined to the participants as ‘children, other family
members, friends, colleagues and so on’. On the basis of the
explorative factor analysis, four subscales of the questionnaire
were extracted: ‘Partner Avoidance’, ‘Partner Support’, ‘Other
Avoidance’ and ‘Other Support’ (Hansen, 2008). Each subscale
consisted of five items, and each item was scored on a 4-point
Likert scale ranging from 0 (‘not at all’) to 3 (‘very much’). A mean
item score was constructed for each subscale, and the minimum
and maximum scores of each subscale were 0 and 3, respectively.
Examples of items from the Partner Avoidance subscale are
‘My partner minimised my concerns’ and ‘My partner avoided
talking about cancer’, and a high score reflected high Partner
Avoidance. Examples of items from the Partner Support subscale
are ‘My partner asked about my symptoms’ and ‘My partner
advised me to talk to my physician’, and a high score reflected high
Partner Support. The Partner Avoidance and Partner Support
subscales were only completed by patients with a partner.
Examples of items from the Other Avoidance subscale are ‘Others
minimised my concerns’ and ‘Others were not worried’, and a high
score reflected high Other Avoidance. Examples of items from the
Other Support subscale are ‘Others took the initiative to talk about
my concerns’ and ‘Others advised me to talk to my physician’, and
a high score reflected high Other Support. In this study, the
Partner Avoidance subscale had a Cronbach’s a¼0.7. All other
subscales had a Cronbach’s alpha of X0.8.
Covariates
For each patient, information about age, gender and cancer
diagnosis was obtained from the HDR. Information on educational
level, relationship status, family history of cancer and disclosure of
symptoms was provided by the patient. Education was categorised
into three levels: (1) lower secondary or none (UNESCO level 0–2),
(2) upper secondary (UNESCO level 3–4) and (3) tertiary
(UNESCO level 5–6) (UNESCO, 1997). Regarding relationship
status, patients reported whether they had a partner or perceived
themselves to be single at the time of diagnosis. The family history
of cancer was assessed asking the patient to consider the following
statement: ‘Many of my relatives have had a cancer disease’. If the
patient responded ‘true’ or ‘mainly true’, they were classified as
having ‘many relatives with cancer’, and if the response was ‘false’
or ‘mainly false’, they were classified as having ‘few relatives with
cancer’. Patients with a partner were asked whether they had
disclosed their symptoms to their partners and/or to other
individuals in the social network. Single patients were asked to
report whether they had disclosed their symptoms to someone in
the social network. On the basis of this information, a disclosure
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svariable was constructed reflecting whether the patient had or had
not disclosed his/her symptoms to someone.
Analysis
Data on age, gender and cancer diagnosis were obtained for both
questionnaire responders and non-responders. Differences
between responders and non-responders were explored with w
2
and Student’s t-tests for independent variables. A mean item score
for each of the four social support subscales was calculated for
patients with a maximum of one missing item per subscale.
Univariate and multivariate multinomial logistic regression
analyses were used to examine associations between social support
subscales, covariates and the three categories of PD (short,
medium and long). Patients with a medium PD were compared
with patients with a short PD and with patients with a long PD. The
multivariate multinomial logistic regression analysis only included
patients in a relationship, as the Partner Avoidance and Partner
Support subscales were only completed by this group of patients.
The following covariates were entered into the multivariate
analysis: age, educational level (lower secondary or none vs upper
secondary and tertiary combined, and tertiary vs upper secondary
and lower secondary or none combined) and family history of
cancer. The multinomial logistic regression analyses were con-
ducted separately for male and female cancer patients. Statistical
significance was determined at a P-value less than or equal to 0.05.
RESULTS
The questionnaires were completed by 1252 (53%) of the 2356
patients with a confirmed cancer diagnosis. An analysis of non-
responders revealed no differences between respondents and non-
respondents with regard to age, gender or diagnoses (data not
shown). Of the 1252 questionnaire responses, 260 had to be
excluded as the patients did not provide sufficient data for
calculation of PD. Another 82 patients were excluded as they had
more than one missing item per social support subscale. Hence,
data on 910 cancer patients were included in the analyses.
Excluded patients (mean¼67.6, s.d.¼13.1) were significantly
older than included patients (mean¼61.8, s.d.¼14.0; t¼6.63,
Po0.001), but no gender differences were revealed between
excluded and included patients (w
2¼0.42, P¼0.516).
Sociodemographic characteristics of female and male patients
are shown in Table 1. Male cancer patients were older than female
patients, and more male than female cancer patients were in a
relationship.
It should be noted that male patients reported more Partner
Support than female patients, and that female patients reported
more Partner Avoidance and Other Support than men. No
difference in Other Avoidance between female and male patients
was observed.
No difference was found between female and male patients with
regard to the number of patients who had disclosed their
symptoms to someone. Table 2 shows to whom female and male
patients with a partner disclosed their symptoms.
The median PD was 12 days (range: 0–843 days). The 25th and
75th percentiles of PD were 1 day and 55 days, respectively. Hence,
a short PD was p1 day, a medium PD was 2–55 days and a long
PD was 455 days. Mean scores and standard deviations of the four
social support subscales in the three PD groups are shown in
Table 3.
The unadjusted relationships between the length of PD and each
of the social support measures are shown in Table 4. In female
patients, no differences in social support subscales and covariates
were observed between patients with a short and a medium PD.
When female patients with a long PD were compared with female
patients with a medium delay, Partner Support, Other Avoidance
and Other Support were found to be associated with PD. Hence,
increasing levels of Partner Support and Other Support signifi-
cantly reduced the likelihood of having a long PD, whereas
increasing levels of Other Avoidance significantly increased the
likelihood of having a long PD in female cancer patients. Finally,
the univariate analyses revealed that disclosure of symptoms
significantly reduced the likelihood of having a long PD in female
patients. The results of adjusting for the possible influence of age,
educational level and family history of cancer are also shown in
Table 4 together with all four social support measures. In female
cancer patients, none of the support subscales and none of the
covariates differed significantly between patients with a medium and
a short PD. Levels of Other Avoidance and disclosure still differed
between female patients with a medium and a long PD. Hence,
female patients reporting high levels of Other Avoidance were more
likely to have a long PD, and female patients who had disclosed their
symptoms to others were less likely to have a long PD.
Table 1 Sociodemographic characteristics and perceived reactions of
the partner and others
Characteristic
Women
(n¼487)
Men
(n¼423) P-value
Continuous variables Mean (s.d.) Mean (s.d.)
Age (years) 59.8 (14.7) 64.2 (12.8) o0.001
Social support subscales
Partner Avoidance 0.68 (0.59) 0.48 (0.45) o0.001
Partner Support 1.47 (0.71) 1.67 (0.72) o0.001
Other Avoidance 0.57 (0.61) 0.51 (0.53) 0.13
Other Support 1.35 (0.70) 1.04 (0.69) o0.001
Categorical variables N (%) N (%)
Educational level
Lower secondary or none 126 (25.9) 86 (20.3) 0.10
Upper secondary 198 (40.7) 195 (46.1)
Tertiary 149 (30.6) 131 (31.0)
Missing information 14 (2.9) 11 (2.6)
Relationship status
In a relationship 337 (69.2) 361 (85.3) o0.001
Single 150 (30.8) 62 (14.7)
Many relatives with cancer
No 301 (61.8) 279 (66.0) 0.33
Yes 172 (35.3) 139 (32.9)
Missing information 14 (2.9) 5 (1.2)
Disclosure
No 83 (17.0) 76 (18.0) 0.67
Yes 393 (80.7) 334 (79.0)
Missing information 11 (2.3) 13 (3.1)
Table 2 Description of to whom female (N¼337) and male patients
(N¼361) with a partner disclosed their symptoms
Symptoms disclosed to:
Female patients
in a relationship,
N (%)
Male patients
in a relationship,
N (%)
The partner only 79 (23.4) 118 (32.7)
Other members of the network only 11 (3.3) 0 (0.0)
Both the partner and other
members of the network
198 (58.8) 179 (49.6)
Neither the partner nor other
members of the network
45 (13.4) 54 (15.0)
Missing information 4 (1.2) 10 (2.3)
Relationship between perceived social support and PD
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sIn male cancer patients, the factors found to be associated with
PD in the univariate analyses were Other Support and relationship
status. Thus, the likelihood of having a long PD increased
significantly with decreasing levels of Other Support. This
association was not maintained in the multivariate analysis. Male
patients in a relationship were less likely to have a long PD. In the
adjusted analysis, Partner Support was the only factor significantly
associated with PD in male cancer patients. Hence, increasing
levels of Partner Support significantly reduced the likelihood of
having a long PD.
DISCUSSION
We found that social support was associated with the length of PD
in patients with various cancer diseases. Results of univariate
analyses revealed that female patients with a long PD reported less
Partner and Other Support and more Other Avoidance than female
patients with a medium PD. Moreover, female patients with a long
PD were more likely not to have disclosed their symptoms to
someone close to them. In male patients, being in a relationship
reduced the risk of a long PD in the univariate analyses. One
possible explanation for the Other Support and Other Avoidance
subscales being significantly associated with PD in female patients
but not with PD in male patients could be that more female
patients than male patients were single. Thus, more female patients
than male patients had to rely on social support from other sources
than a partner.
In the multivariate analysis, Other Avoidance and disclosure of
symptoms remained significantly associated with the length of PD
in female cancer patients. In the multivariate analysis where
relationship status was omitted, as only patients in a relationship
were included in the analysis, the results revealed that male
patients with a long PD reported less Partner Support than male
patients with a medium PD.
The patterns of use of the social network observed in this study
correspond to results of previous studies. Thus, we found that PD
in female patients was influenced by both partner and Other
Support and that Other Avoidance, in the multivariate analysis,
was a more important factor for the length of PD than social
support from the partner. In male patients, being in a relationship
and receiving support from the partner were the two most
important factors for reducing the length of PD. In agreement with
these findings, previous studies have suggested that women have
larger networks and are more likely to rely on friends and children
for emotional support than men who are more likely to rely
exclusively on their partners (Antonucci and Akiyama, 1987;
Umberson, 1992; Ye et al, 2009). Moreover, one study found that
men experienced greater distress when exposed to social
constraints from their spouse than did women (Zakowski et al,
2003).
The results of this study showed that female cancer patients
reported more Partner Avoidance than male patients who, on the
contrary, reported more Partner Support than female patients. The
higher levels of perceived Partner Support observed in male
patients correspond to previous results (Kristofferzon et al, 2003;
Goldzweig et al, 2009). We are not able to explain why female
patients reported more Partner Avoidance than male patients, but
in accordance with our results, it has previously been shown that
women with a serious disease such as cancer receive less support
from their partners than men with a serious disease do
(Kristofferzon et al, 2003; Luszczynska et al, 2007). Recently, it
has been suggested that most husbands and wives are equally
skilled at providing support, but that wives are more responsive to
their partners’ changing needs over time (Neff and Karney, 2005).
On the basis of this, it could be anticipated that women are more
sensitive to possible incongruity between the support that is
needed and the support that is provided and, therefore, report
more avoidant behaviour from the partner than men do.
Interestingly, in female patients disclosure of symptoms to
someone was a more important factor for reducing the length of
PD than being in a relationship. In agreement with this finding,
one study of breast cancer patients showed that patients who did
not disclose their symptoms to someone close to them were more
likely to delay medical help-seeking (Burgess et al, 1998). In this
study, nearly 60% of the female patients who were in a relationship
had disclosed their symptoms to both the partner and other
members of the social network. Approximately 14% of the female
patients in a relationship had not disclosed their symptoms to
anyone, and 3% of the female patients in a relationship had
disclosed their symptoms to someone in the social network, but
not to the partner. Further studies are needed in order to examine
what these patterns of disclosure reflect, and whether the group of
female patients in a relationship who do not disclose their
symptoms to their partners is a group with special needs with
regard to reducing the length of PD. According to the interpersonal
process model of intimacy, self-disclosure is a key concept and is
assumed to be a prerequisite of supportive relationships (Manne
et al, 2004a,b, 2010; Manne and Badr, 2009). By not disclosing the
symptom to the partner, the individual who experiences a
symptom obviously prevents himself from being encouraged to
talk to the GP. Results from previous qualitative (Zola, 1973;
de Nooijer et al, 2001; Scott et al, 2006, 2009) and quantitative
studies (Eriksson et al, 2004) have revealed that the partner’s
worries are important triggers of consultations with the GP. The
decision of the individual experiencing a symptom not to disclose
the illness-related worries to the healthy partner might reflect
thoughtfulness, but the lack of self-disclosure may also reflect low
Table 3 Mean item scores and s.d. on the four social support subscales in patient delay groups
Patient delay groups
Short patient delay
mean item score (s.d.)
Medium patient delay
mean item score (s.d.)
Long patient delay
mean item score (s.d.)
Female patients
Partner support 1.62 (0.70) 1.52 (0.70) 1.23 (0.68)
Partner avoidance 0.60 (0.55) 0.66 (0.57) 0.79 (0.67)
Other support 1.41 (0.71) 1.40 (0.66) 1.18 (0.74)
Other avoidance 0.48 (0.59) 0.52 (0.54) 0.76 (0.70)
Male patients
Partner support 1.78 (0.66) 1.67 (0.74) 1.54 (0.43)
Partner avoidance 0.44 (0.44) 0.53 (0.46) 0.42 (0.43)
Other support 1.19 (0.71) 0.94 (0.72) 1.03 (0.60)
Other avoidance 0.48 (0.53) 0.54 (0.55) 0.49 (0.51)
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squality of the marital relationship and lack of relationship
intimacy (Manne et al, 2004a; Badr and Taylor, 2006). Studies
have shown that patients and their spouses in general find it
difficult to talk about health-related worries, and that mutual social
constraints are possibly greater in couples experiencing a relation-
ship crisis (Badr and Taylor, 2006). Moreover, when a couple
experiences distress, medical help-seeking may be impeded as
actions aimed at making the relationship work are the number one
priority (Scott et al, 2006). Unfortunately, the quality of the marital
relationships was not addressed in this study. This issue and its
influence on PD have to be investigated further in future studies.
The finding of this study suggesting that men rely on the partner
only when discovering a symptom could indicate that singlehood
has detrimental consequences to men, in particular concerning the
health status. Results have shown that beginning a conversation
about symptoms or health issues is in contrast to the images of
masculinity of many men (Gascoigne et al, 1999) and, therefore, it
may be a difficult task to alter the observed patterns of behaviour
when men are confronted with a health threat. Insofar that the
patterns of behaviour are difficult to change, the results of this
study are suggestive that cancer awareness campaigns should be
designed differently when targeted men or women. Women may
Table 4 Results of univariate and multivariate multinomial logistic models in female and male cancer patients
Dependent variable: length of patient delay
Short: p1 day Long: 455 days
Medium: 2–55 days
Unadjusted Adjusted
b Unadjusted Adjusted
b
(Reference)
a RRR 95% CI
c P-value RRR 95% CI
c P-value RRR 95% CI
c P-value RRR 95% CI
c P-value
Female cancer patients (N¼487)
Partner avoidance 0.83 0.51–1.35 0.45 0.78 0.39–1.54 0.47 1.43 0.94–2.18 0.10 0.73 0.38–1.38 0.33
Partner support 1.22 0.83–1.79 0.32 1.16 0.68–1.98 0.57 0.54 0.37–0.80 0.002 0.62 0.36–1.07 0.09
Other avoidance 0.88 0.59–1.32 0.55 1.31 0.69–2.48 0.41 1.81 1.25–2.60 0.002 2.54 1.40–4.59 0.002
Other support 1.02 0.75–1.41 0.89 0.99 0.57–1.73 0.97 0.63 0.45–0.89 0.009 0.76 0.43–1.34 0.35
Age 1.00 0.99–1.02 0.63 1.00 0.98–1.02 0.94 0.99 0.97–1.00 0.08 1.00 0.98–1.02 0.92
Educational level
Lower secondary
d 0.59 0.38–0.93 0.02 0.71 0.32–1.55 0.39 0.61 0.38–0.96 0.03 0.79 0.36–1.74 0.56
Tertiary
e 1.24 0.78–1.97 0.36 0.87 0.37–2.07 0.75 1.17 0.72–1.89 0.52 1.30 0.55–3.08 0.56
Relationship status
Single (ref) 1.00 1.00
In a relationship 0.65 0.42–1.01 0.06 Omitted
f 1.59 0.94–2.69 0.08 Omitted
f
Relatives with cancer
Few (ref) 1.00 1.00 1.00 1.00
Many 1.15 0.73–1.80 0.55 1.56 0.84–2.92 0.16 1.17 0.74–1.86 0.51 1.10 0.58–2.08 0.77
Disclosure of symptoms
No disclosure (ref) 1.00 1.00 1.00
Disclosure 0.69 0.38–1.26 0.23 0.68 0.23–2.03 0.49 0.35 0.20–0.62 o0.001 0.25 0.10–0.63 0.003
Male cancer patients (N¼423)
Partner avoidance 0.63 0.36–1.11 0.11 0.87 0.45–1.67 0.67 0.57 0.32–1.04 0.07 0.73 0.37–1.47 0.38
Partner support 1.24 0.87–1.77 0.24 0.95 0.61–1.47 0.81 0.77 0.54–1.10 0.15 0.54 0.34–0.85 0.008
Other avoidance 0.81 0.52–1.26 0.35 0.71 0.41–1.24 0.23 0.83 0.53–1.32 0.44 0.85 0.49–1.47 0.56
Other support 1.68 1.19–2.38 0.003 1.47 0.95–2.27 0.09 1.22 0.85–1.74 0.27 1.25 0.78–2.02 0.35
Age 0.99 0.97–1.01 0.33 0.99 0.97–1.01 0.25 0.98 0.96–1.00 0.05 0.98 0.96–1.00 0.08
Educational level
Lower secondary
d 1.18 0.75–1.87 0.48 1.01 0.47–2.15 0.99 0.91 0.57–1.47 0.71 0.99 0.44–2.24 0.99
Tertiary
e 0.69 0.41–1.14 0.15 0.86 0.37–2.01 0.73 1.01 0.61–1.67 0.97 1.19 0.50–2.87 0.70
Relationship status
Single (ref) 1.00 1.00
In a relationship 0.54 0.28–1.04 0.07 Omitted
f 0.51 0.26–1.00 0.05 Omitted
f
Relatives with cancer
Few (ref) 1.00 1.00 1.00 1.00
Many 1.14 0.71–1.85 0.58 1.20 0.67–2.16 0.55 0.82 0.49–1.36 0.44 1.18 0.63–2.19 0.61
Disclosure of symptoms
No disclosure (ref) 1.00 1.00 1.00 1.00
Disclosure 1.57 0.82–2.98 0.17 1.27 0.55–2.89 0.58 0.82 0.46–1.46 0.50 0.83 0.39–1.81 0.65
Abbreviation: RRR¼relative risk ratio.
aReference refers to the group that all other groups are compared with in the multinomial model.
bOnly patients with a partner were
included in the multivariate multinomial regression analyses (N¼337 and 361 for females and males, respectively).
c95% Confidence interval for relative risk ratio.
dPatients with
lower secondary education or no education were compared with patients with upper secondary education and patients with tertiary education combined (reference).
ePatients
with tertiary education were compared with patients with lower secondary or no education and patients with upper secondary education combined (reference).
fThe variable
‘Relationship status’ was omitted from the multivariate multinomial regression analyses as these analyses only included patients with a partner.
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children or friends, whereas awareness campaigns aimed at
improving partnered men’s health should motivate men to discuss
health issues with their partner or – as a more radical suggestion –
should teach women how to be attentive to the health of their
husbands. Further research is needed in order to clarify how to
address the needs of single men.
Instead of using the 25th and 75th percentiles for categorising PD,
we could have used the conventional cut-off on 3 months. However,
this cut-off, introduced by Pack and Gallo (1938), has been criticised
for not being based on evidence (Scott and Walter, 2010).
Alternatively, cut-offs considered to be clinically meaningful could
have been used, but as patients with various forms of cancers with
different clinical guidelines for seeking medical attention were
included in this study, the use of clinically meaningful cut-offs did
not appear appropriate. Optimally, the time taken to seek medical
help is treated as a continuous variable, but as a consequence of
skewed data it is recommended that the median are presented to
prevent extreme cases (Scott and Walter, 2010). We followed this
recommendation and widened it by using the 25th and 75th
percentiles, which allowed us to examine whether those patients with
an extremely short delay differed from patients with a medium PD.
Some limitations of this study should be noted. First, 260 of the
questionnaire responses were excluded as the patients did not
provide sufficient data concerning the length of PD, and further
82 patients were excluded as a consequence of missing responses
on the social support subscales. The excluded patients were older
than the included patients. There is no conclusive evidence that
age is associated with the length of PD (Macleod et al, 2009), but as
age is likely to be associated with relationship status and the size of
the social network, the exclusion of patients may have caused
selection bias of unknown size and direction. Second, as a
consequence of the cross-sectional study design, direction of
causality cannot be determined. Third, the study is retrospective
and the risk of possible recall bias cannot be excluded. However,
the risk of reduced reliability and validity are well-known
methodological limitations in studies of PD (Andersen et al,
2009). Fourth, this study revealed differences in the levels of social
support between patients with a medium and a long PD. The
multivariate analyses, however, revealed no differences between
patients with a medium and a short PD. As all other groups were
compared with the group of patients with a medium PD, the results
did not show whether patients with a long delay differed from
patients with a short delay. As both a very long and a very short PD
may reflect inappropriate illness behaviour, future studies should
examine the differences between these groups. Fifth, the multi-
variate analysis was based on patients in a relationship only, and
the number of single patients was rather low reducing the
statistical power below acceptable levels when performing analyses
with this group of patients. Thus, further studies are needed in
order to examine whether patients without a partner differ in how
social support affects them compared with patients with a partner.
In conclusion, the results of this study revealed that less Partner
Support, less Other Support, more Other Avoidance and non-
disclosure of the symptom(s) were associated with a long PD in
female cancer patients. In the multivariate analysis, including only
patients in a relationship, non-disclosure of symptom(s) and Other
Avoidance remained to be significantly associated with a long PD
in female cancer patients. In male cancer patients, being in a
relationship and Partner Support were the factors most strongly
associated with decreased risk of a long PD. The results of this
study suggest that female and male cancer patients differ in their
ways of using the social network when exposed to a health threat,
and these gender differences may explain some of the mixed
findings in previous studies examining the relationship between
social support and PD.
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APPENDIX
Partner Support (Cronbach’s a¼0.79)
My partner asked about my symptoms
My partner took the initiative to talk about my concerns
My partner advised me to talk to my physician
My partner tried to calm me
My partner talked directly about cancer
Partner Avoidance (Cronbach’s a¼0.71)
My partner minimised my concerns
My partner pretended nothing had happened
My partner avoided talking about cancer
My partner hid his/her concerns
My partner was not worried
Other Support (Cronbach’s a¼0.79)
Other asked about my symptoms
Other took the initiative to talk about my concerns
Other advised me to talk to my physician
Other tried to calm me
Other talked directly about cancer
Other Avoidance (Cronbach’s a¼0.81)
Other minimised my concerns
Other pretended nothing had happened
Other avoided talking about cancer
Other hid his/her concerns
Other was not worried
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